SGLT-2 inhibitors (including empagliflozin, dapagliflozin, and canagliflozin) provide another option through their insulin-independent mechanism of increasing urinary glucose excretion
SURMOUNT-1 and TRIUMPH-4 enrolled different populations (TRIUMPH-4 included only people with knee osteoarthritis), and direct head-to-head trials comparing retatrutide and tirzepatide havent been completed
Mariana Islands, Comoros, Cook Islands, Cte d'Ivoire, Cuba, Falkland Islands, Faroe Islands, Federated States of Micronesia, Georgia, Greenland, Guam, Guinea Republic, Guinea-Bissau, India, Iran (Islamic Republic of), Iraq, Kazakhstan, Kiribati, Kosovo, Kyrgyzstan, Marshall Islands, Mauritania, Nepal, Niue, North Macedonia, Palau, Republic of Moldova, Republic of Nauru, Republic of Yemen, The D.P.R
They offer 47 products (APIs, Excipients or Intermediates)
A new branded semaglutide drug named Poviztra was introduced in India by Emcure Pharmaceuticals in 2025 for USD 103 a month, well under the prices offered by competing drugs, ranging between USD 165 and 324
Foundayo (orforglipron) is another oral GLP-1 option, offering flexibility, as it can be taken anytime without food or drink restrictions